Below are links to research studies for inflammatory or infectious diseases. If you are thinking of taking part in one, please talk to your doctor.

• RAPID-1 - Phase IIb, randomised, double-blind, placebo-controlled, multi-centre trial of infliximab with transcriptomic biomarker and mechanism evaluation in patients with acute pancreatitis

• Socio-economic risk factors for antibiotic resistance (SEARCHING study)

• EXTENDed antibiotic durations for abdominal infections - Scotland

• Rheumatoid Arthritis - assessing the use of TOCILIZUMAB biosimilar in treatment of patients over a 12 month period

• UK Antimicrobial Registry (UKAR) Study